1 |
Shivashankar R, Singh K, Aravind LR, Tandon N. Diabetes Management in Asia. In: Rodriguez-saldana J, editor. The Diabetes Textbook. Cham: Springer International Publishing; 2019. pp. 239-53. [DOI: 10.1007/978-3-030-11815-0_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
2 |
Tien KJ, Hung YJ, Chen JF, Chen CC, Wang CY, Hwu CM, Huang YY, Hsiao PJ, Tu ST, Wang CH, Sheu WH. Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment. J Diabetes Investig 2019;10:560-70. [PMID: 30520564 DOI: 10.1111/jdi.12984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
3 |
Seino Y, Yabe D. Alogliptin benzoate for the treatment of type 2 diabetes. Expert Opin Pharmacother. 2014;15:851-863. [PMID: 24646052 DOI: 10.1517/14656566.2014.898750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
4 |
Ma RC, Del Prato S, Gallwitz B, Shivane VK, Lewis-D'Agostino D, Bailes Z, Patel S, Lee J, von Eynatten M, Di Domenico M, Ross SA. Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial. J Diabetes Investig 2017. [PMID: 28921919 DOI: 10.1111/jdi.12746] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
5 |
Mu Y, Pan C, Fan B, Hehnke U, Zhang X, Zhang X, Wang X, Liu J, Zhang Y, Du J, Ma J, Gong Y. Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes. Diabetes Res Clin Pract 2017;124:48-56. [PMID: 28088030 DOI: 10.1016/j.diabres.2016.11.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|